ANI PHARMACEUTICALS INC (ANIP)
US00182C1036 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 18.78M | -47.90M | -42.60M | -22.55M | 6.09M | |||
| Depreciation Amortization | 59.79M | 59.65M | 47.25M | 44.64M | 44.61M | |||
| Income Taxes - Deferred | -11.74M | -15.25M | -16.75M | -13.21M | -9.13M | |||
| Change In Working Capital | 24.86M | -51.30M | -80.00K | -12.63M | -14.58M | |||
| Interest Paid | 31.43M | 21.48M | 9.71M | 6.93M | 6.09M | |||
| Taxes Paid | 1.23M | 290.00K | 10.37M | 4.98M | 10.03M | |||
| Other non cash items | 27.27M | 23.59M | 15.51M | 19.01M | 18.64M | |||
| OPERATING CASH FLOW | 118.96M | -31.20M | 3.32M | 15.27M | 45.63M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -8.87M | -8.88M | -2.56M | -6.14M | -6.64M | |||
| Other Investing Activity | -9.64M | -6.86M | -102.93M | -62.19M | -20.91M | |||
| INVESTING CASH FLOW | -18.51M | -15.74M | -105.48M | -68.32M | -27.55M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -3.00M | -3.00M | 112.99M | -530.00K | -3.46M | |||
| Stock Issued/Repurchased | 84.56M | -500.00K | 101.18M | -910.00K | 4.71M | |||
| Dividend Paid | -1.63M | -1.63M | -190.00K | N/A | N/A | |||
| Other Financing Activity | -12.50M | 0.00 | -19.38M | N/A | 0.00 | |||
| FINANCING CASH FLOW | 67.44M | -5.13M | 194.60M | -1.44M | 1.25M | |||
| CHANGE IN CASH | 167.89M | -52.07M | 92.44M | -54.49M | 19.33M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 118.96M | -31.20M | 3.32M | 15.27M | 45.63M | |||
| Capital Expenditure | -8.87M | -8.88M | -2.56M | -6.14M | -6.64M | |||
| FREE CASH FLOW | 110.09M | -40.08M | 760.00K | 9.13M | 38.99M | |||
All data in USD